osteogenic differentiation medium (Beijing Solarbio Science)
Structured Review

Osteogenic Differentiation Medium, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 99/100, based on 10045 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/osteogenic+differentiation+medium/pmc13088540-36-2-17?v=Beijing+Solarbio+Science
Average 99 stars, based on 10045 article reviews
Images
1) Product Images from "Engineering a vascularized-osteogenic microenvironment to enhance bone regeneration via a 3D-printed composite scaffold with progressive-release bio-factors"
Article Title: Engineering a vascularized-osteogenic microenvironment to enhance bone regeneration via a 3D-printed composite scaffold with progressive-release bio-factors
Journal: Journal of Translational Medicine
doi: 10.1186/s12967-026-08090-5
Figure Legend Snippet: Characterization of biocompatibility and osteogenic inductive capacity of scaffold materials. (a) Cytotoxicity assessment of PCL, PHA, and PHL scaffolds against bone marrow mesenchymal stem cells (BMSCs) via Live/Dead staining. Green: Calcein-AM (live cells), Red: Propidium iodide (PI, apoptotic cells) (Scale bar = 200 μm). (b) Proliferation and viability of BMSCs co-cultured with scaffolds for 1, 3, and 5 days, determined by CCK-8 assay. (c) Representative images of scratch wound healing assay (Scale bar = 200 μm). (d) Quantitative analysis of cell migration rate. (e) Alkaline phosphatase (ALP) staining of BMSCs after osteogenic differentiation induction (Scale bar = 200 μm). (f) ALP staining of BMSCs directly co-cultured with scaffolds without osteogenic supplements(Scale bar=1 mm). (g) Alizarin red S (ARS) staining of BMSCs after osteogenic differentiation induction (Scale bar = 200 μm). (h) ARS staining of BMSCs directly co-cultured with scaffolds without osteogenic supplements(Scale bar=1 mm). (i) Quantitative analysis of ALP-positive staining area. (j) Quantitative analysis of ARS-positive mineralized nodule area. All experimental data are expressed as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001
Techniques Used: Staining, Cell Culture, CCK-8 Assay, Wound Healing Assay, Migration
Figure Legend Snippet: Osteogenic promotion of GV@PHL scaffold in vivo. ( a ) Schematic illustration of critical-size bone defect modeling in SD rats and GV@PHL transplantation. (b) Macroscopic images of rat calvarial bone defects treated with different scaffolds at 6 weeks. (c) Bone defect traces and defect rates of each experimental group after various treatments. (d) Micro-CT 3D reconstruction images of rat calvarial bone defects treated with different scaffolds at 6 weeks post-surgery. e-h) Bone mineral density (BMD), bone volume/tissue volume (BV/TV), bone surface/total volume (BS/TV), and trabecular number (Tb.N) of bone defects treated with different scaffolds. i-j) HE staining and Masson trichrome staining results of each group (black scale bar = 1 mm, red scale bar = 50 μm). All experimental data are expressed as mean ± SD ( n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001
Techniques Used: In Vivo, Transplantation Assay, Micro-CT, Staining
